A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT04767529. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Non-Cirrhotic Subjects With Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in non-cirrhotic subjects with biopsy-proven F2 - F3 NASH.
Study identification
- NCT ID
- NCT04767529
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 16, 2021 (Actual)
- Primary completion
- May 2, 2024 (Actual)
- Completion
- May 2, 2024 (Actual)
- Last update posted
- Jun 18, 2025
2021 – 2024
United States locations
- U.S. sites
- 54
- U.S. states
- 16
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Akero Clinical Study Site | Chandler | Arizona | 85224 | — |
| Akero Clinical Study Site | Glendale | Arizona | 85304 | — |
| Akero Clinical Study Site | Tucson | Arizona | 85712 | — |
| Akero Clinical Study Site | North Little Rock | Arkansas | 72117 | — |
| Akero Clinical Study Site | Chula Vista | California | 91910 | — |
| Akero Clinical Study Site | Fresno | California | 93720 | — |
| Akero Clinical Study Site | La Jolla | California | 92037 | — |
| Akero Clinical Study Site | Los Angeles | California | 90036 | — |
| Akero Clinical Study Site | Los Angeles | California | 90048 | — |
| Akero Clinical Study Site | Los Angeles | California | 90057 | — |
| Akero Clinical Study Site | Orange | California | 92866 | — |
| Akero Clinical Study Site | Panorama City | California | 91402 | — |
| Akero Clinical Study Site | Rialto | California | 92866 | — |
| Akero Clinical Study Site | Santa Ana | California | 92704 | — |
| Akero Clinical Study Site | Fort Myers | Florida | 33912 | — |
| Akero Clinical Study Site | Inverness | Florida | 34452 | — |
| Akero Clinical Study Site | Lakewood Rch | Florida | 34211 | — |
| Akero Clinical Study Site | Miami | Florida | 33134 | — |
| Akero Clinical Study Site | Miami | Florida | 33147 | — |
| Akero Clinical Study Site | Miami Lakes | Florida | 33016 | — |
| Akero Clinical Study Site | Ocala | Florida | 34471 | — |
| Akero Clinical Study Site | Sarasota | Florida | 94240 | — |
| Akero Clinical Study Site | Marietta | Georgia | 30060 | — |
| Akero Clinical Study Site | Topeka | Kansas | 66606 | — |
| Akero Clinical Study Site | Baton Rouge | Louisiana | 70809 | — |
| Akero Clinical Study Site | Marrero | Louisiana | 70072 | — |
| Akero Clinical Study Site | Ypsilanti | Michigan | 48197 | — |
| Akero Clinical Study Site | Flowood | Mississippi | 39232 | — |
| Akero Clinical Study Site | Jackson | Mississippi | 39216 | — |
| Akero Clinical Study Site | Las Vegas | Nevada | 89106 | — |
| Akero Clinical Study Site | Charlotte | North Carolina | 28204 | — |
| Akero Clinical Study Site | Durham | North Carolina | 27712 | — |
| Akero Clinical Study Site | Morehead City | North Carolina | 28557 | — |
| Akero Clinical Study Site | Cincinnati | Ohio | 45219 | — |
| Akero Clinical Study Site | Greenville | South Carolina | 29605 | — |
| Akero Clinical Study Site | Hermitage | Tennessee | 37076 | — |
| Akero Clinical Study Site | Nashville | Tennessee | 37211 | — |
| Akero Clinical Study Site | Arlington | Texas | 76012 | — |
| Akero Clinical Study Site | Austin | Texas | 78757 | — |
| Akero Clinical Study Site | Cedar Park | Texas | 75246 | — |
| Akero Clinical Study Site | Dallas | Texas | 75234 | — |
| Akero Clinical Study Site | Dallas | Texas | 75246 | — |
| Akero Clinical Study Site | Edinburg | Texas | 78539 | — |
| Akero Clinical Study Site | Fort Worth | Texas | 76104 | — |
| Akero Clinical Study Site | Garland | Texas | 75044 | — |
| Akero Clinical Study Site | Houston | Texas | 77058 | — |
| Akero Clinical Study Site | San Antonio | Texas | 78209 | — |
| Akero Clinical Study Site | San Antonio | Texas | 78215 | — |
| Akero Clinical Study Site | San Antonio | Texas | 78229 | — |
| Akero Clinical Study Site | San Marcos | Texas | 78666 | — |
| Akero Clinical Study Site | Webster | Texas | 77598 | — |
| Akero Clinical Study Site | Charlottesville | Virginia | 22908 | — |
| Akero Clinical Study Site | Richmond | Virginia | 23249 | — |
| Akero Clinical Study Site | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04767529, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04767529 live on ClinicalTrials.gov.